The OECD Health Division is releasing a new series to highlight its work on health policies and data. A new graph will be available each month.
Français, PDF, 861kb
Lutter contre le gaspillage et intégrer les nouvelles technologies - Présentation à l'Ajef lors de la sortie du rapport, 12 janvier 2017.
Français, PDF, 1,370kb
Cette synthèse est une traduction partielle en français du rapport et contient l’avant-propos, les remerciements, la table des matières, le résumé ainsi que le chapitre 1.
This High-Level Forum will be held at the OECD Conference Centre in Paris on 16 January 2017. Issues include: Harnessing digital technology and data to create proactive, people-centred systems; Overcoming technical, institutional and cultural challenges; Caring for people with complex needs; The importance of measuring what matters to people and to patients, and The role of international and cross-sector collaboration.
English, PDF, 1,422kb
Patient-Reported Indicators Survey: Explanatory Booklet
English, PDF, 1,816kb
Recommendations to OECD Ministers of Health from the High-Level Reflection Group on the Future of Health Statistics: Strengthening the international comparison of health system performance through patient-reported indicators.
This report discusses the need for an integrated and cyclical approach to managing health technology in order to mitigate clinical and financial risks, and ensure acceptable value for money. The analysis considers how health systems and policy makers should adapt in terms of development, assessment and uptake of health technologies. The first chapter provides an examination of adoption and impact of medical technology in the past and how health systems are preparing for continuation of such trends in the future. Subsequent chapters examine the need to balance innovation, value, and access for pharmaceuticals and medical devices, respectively, followed by a consideration of their combined promise in the area of precision medicine. The final chapter examines how health systems can make better use of health data and digital technologies. The report focuses on opportunities linked to new and emerging technologies as well as current challenges faced by policy makers, and suggests a new governance framework to address these challenges.
OECD Health Care Quality Reviews seek to examine what works and what does not work in different countries – both to benchmark the efforts of countries and to provide advice on reforms to improve their health system.
Following a brief pause after the economic crisis, health expenditure is rising again in most OECD countries. Yet, a considerable part of this health expenditure makes little or no contribution to improving people's health. In some cases, it even results in worse health outcomes. Countries could potentially spend significantly less on health care with no impact on health system performance, or on health outcomes. This report systematically reviews strategies put in place by countries to limit ineffective spending and waste. On the clinical front, preventable errors and low-value care are discussed. The operational waste discussion reviews strategies to obtain lower prices for medical goods and to better target the use of expensive inputs. Finally, the report reviews countries experiences in containing administrative costs and integrity violations in health.
The policy study published by the OECD is based on six case studies, an extensive review of the literature, and analysis of relevant data. The report provides context for the analysis of pharmaceutical pricing policies in OECD countries, describes pricing policies employed by the OECD zone and assesses their impact.